Shilpa Gupta
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center · Alliance for Clinical Trials in Oncology · Cleveland Clinic Taussig Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shilpa Gupta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:03 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05833867 · Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder CancerShilpa Gupta, MD · recruiting · Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma · principal investigator
- Ph3NCT05092958 · Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV StudyNational Cancer Institute (NCI) · active not recruiting · Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma · principal investigator
- Ph2NCT03294304 · BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing CystectomyMasonic Cancer Center, University of Minnesota · completed · Muscle Invasive Bladder Cancer · study chair
- Ph2NCT02988843 · Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell TumorsMasonic Cancer Center, University of Minnesota · terminated · Germ Cell Tumor · principal investigator
- Ph1NCT02300610 · Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerH. Lee Moffitt Cancer Center and Research Institute · completed · Bladder Cancer, Carcinoma, Transitional Cell, Renal Pelvis Cancer · study chair
- Ph2NCT01560923 · Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMasonic Cancer Center, University of Minnesota · completed · Metastatic Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Molecular Characterization TrialU54CA274513 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · fiscal years 2025 to 2026 · $131,487 awarded in 2026Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT05092958
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:03 UTC. The ranking covers the 200 most relevant of 946 PubMed records, and a shared surname and initials can bring in a namesake. All 946 on PubMed
- 2,611 citationsRCR 66.1
- 2,028 citationsRCR 76.3
- Mepolizumab and exacerbations of refractory eosinophilic asthma.N Engl J Med · 20091,470 citationsRCR 39.4
- 1,002 citationsRCR 130.6
- Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.N Engl J Med · 2015929 citationsRCR 36.5
- The BATTLE trial: personalizing therapy for lung cancer.Cancer Discov · 2011649 citationsRCR 13.9
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.Lancet Oncol · 2015443 citationsRCR 12.2
- Human bocavirus and acute wheezing in children.Clin Infect Dis · 2007428 citationsRCR 12.2
- Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.J Transl Med · 2014413 citationsRCR 15.5
- An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.Gastroenterology · 2011364 citationsRCR 10.8